Reviewing the role of progesterone therapy in endometriosis

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Endometriosis is a benign, chronic inflammatory condition characterized by the presence and growth of endometrial implants outside the uterine cavity. The cause of endometriosis is multifactorial. It is due to the diversity of hypothesis and plausibility of hormonal alterations which could play a major role. Evidence has shown that progesterone resistance is a key factor for endometriosis sufferers. Medical therapy can avoid surgical intervention, which may lead to a reduced in ovarian reserve, and its effects of earlier menopause and reduced fecundity. Progesterone receptor isoform has provided new insight as the potential treatment. Progestin, anti-progestin and selective progesterone receptor modulators usage, which target these receptors, could avoid hypo-estrogenic side effects, which can be debilitating. Numerous types of these medications have been used on and off labeled to treat endometriosis with varying success. This review aims to consolidate series of clinical trials using progestins in endometriosis.

Original languageEnglish
Pages (from-to)10-16
Number of pages7
JournalGynecological Endocrinology
Volume35
Issue number1
DOIs
Publication statusPublished - 2 Jan 2019

Fingerprint

Endometriosis
Progesterone
Progestins
Progesterone Receptors
Therapeutics
Menopause
Fertility
Protein Isoforms
Estrogens
Clinical Trials
Growth

Keywords

  • Endometriosis
  • progesterone
  • progesterone receptor
  • progesterone receptor isoform
  • progestin

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Obstetrics and Gynaecology

Cite this

@article{e06700674a574bb482f15995bcd30141,
title = "Reviewing the role of progesterone therapy in endometriosis",
abstract = "Endometriosis is a benign, chronic inflammatory condition characterized by the presence and growth of endometrial implants outside the uterine cavity. The cause of endometriosis is multifactorial. It is due to the diversity of hypothesis and plausibility of hormonal alterations which could play a major role. Evidence has shown that progesterone resistance is a key factor for endometriosis sufferers. Medical therapy can avoid surgical intervention, which may lead to a reduced in ovarian reserve, and its effects of earlier menopause and reduced fecundity. Progesterone receptor isoform has provided new insight as the potential treatment. Progestin, anti-progestin and selective progesterone receptor modulators usage, which target these receptors, could avoid hypo-estrogenic side effects, which can be debilitating. Numerous types of these medications have been used on and off labeled to treat endometriosis with varying success. This review aims to consolidate series of clinical trials using progestins in endometriosis.",
keywords = "Endometriosis, progesterone, progesterone receptor, progesterone receptor isoform, progestin",
author = "{Abdul Karim}, {Abdul Kadir} and Shafiee, {Mohamad Nasir} and {Abd Aziz}, {Nor Haslinda} and Omar, {Mohd Hashim} and {Abdul Ghani}, {Nur Azurah} and Lim, {Pei Shan} and {Md Zain}, {Reena Rahayu} and {Mohd Mokhtar}, Norfilza",
year = "2019",
month = "1",
day = "2",
doi = "10.1080/09513590.2018.1490404",
language = "English",
volume = "35",
pages = "10--16",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Reviewing the role of progesterone therapy in endometriosis

AU - Abdul Karim, Abdul Kadir

AU - Shafiee, Mohamad Nasir

AU - Abd Aziz, Nor Haslinda

AU - Omar, Mohd Hashim

AU - Abdul Ghani, Nur Azurah

AU - Lim, Pei Shan

AU - Md Zain, Reena Rahayu

AU - Mohd Mokhtar, Norfilza

PY - 2019/1/2

Y1 - 2019/1/2

N2 - Endometriosis is a benign, chronic inflammatory condition characterized by the presence and growth of endometrial implants outside the uterine cavity. The cause of endometriosis is multifactorial. It is due to the diversity of hypothesis and plausibility of hormonal alterations which could play a major role. Evidence has shown that progesterone resistance is a key factor for endometriosis sufferers. Medical therapy can avoid surgical intervention, which may lead to a reduced in ovarian reserve, and its effects of earlier menopause and reduced fecundity. Progesterone receptor isoform has provided new insight as the potential treatment. Progestin, anti-progestin and selective progesterone receptor modulators usage, which target these receptors, could avoid hypo-estrogenic side effects, which can be debilitating. Numerous types of these medications have been used on and off labeled to treat endometriosis with varying success. This review aims to consolidate series of clinical trials using progestins in endometriosis.

AB - Endometriosis is a benign, chronic inflammatory condition characterized by the presence and growth of endometrial implants outside the uterine cavity. The cause of endometriosis is multifactorial. It is due to the diversity of hypothesis and plausibility of hormonal alterations which could play a major role. Evidence has shown that progesterone resistance is a key factor for endometriosis sufferers. Medical therapy can avoid surgical intervention, which may lead to a reduced in ovarian reserve, and its effects of earlier menopause and reduced fecundity. Progesterone receptor isoform has provided new insight as the potential treatment. Progestin, anti-progestin and selective progesterone receptor modulators usage, which target these receptors, could avoid hypo-estrogenic side effects, which can be debilitating. Numerous types of these medications have been used on and off labeled to treat endometriosis with varying success. This review aims to consolidate series of clinical trials using progestins in endometriosis.

KW - Endometriosis

KW - progesterone

KW - progesterone receptor

KW - progesterone receptor isoform

KW - progestin

UR - http://www.scopus.com/inward/record.url?scp=85061963373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061963373&partnerID=8YFLogxK

U2 - 10.1080/09513590.2018.1490404

DO - 10.1080/09513590.2018.1490404

M3 - Review article

C2 - 30044157

AN - SCOPUS:85061963373

VL - 35

SP - 10

EP - 16

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 1

ER -